Insider Transactions in Q2 2020 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
400
-0.28%
|
$244,800
$612.6 P/Share
|
|
Jun 29
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
3,000
-15.3%
|
$1,824,000
$608.51 P/Share
|
|
Jun 23
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
512
-0.26%
|
$322,560
$630.67 P/Share
|
|
Jun 22
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,388
-25.21%
|
$5,250,888
$626.19 P/Share
|
|
Jun 22
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,900
+21.1%
|
$4,939,500
$555.67 P/Share
|
|
Jun 19
2020
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,559
-40.63%
|
$1,612,170
$630.69 P/Share
|
|
Jun 19
2020
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+44.42%
|
$1,000,569
$391.92 P/Share
|
|
Jun 16
2020
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
3,556
-1.38%
|
$2,090,928
$588.96 P/Share
|
|
Jun 15
2020
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,406
+18.3%
|
$385,646
$41.33 P/Share
|
|
Jun 15
2020
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
3,670
-18.06%
|
$2,154,290
$587.9 P/Share
|
|
Jun 11
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
988
-0.36%
|
$607,620
$615.59 P/Share
|
|
Jun 11
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,706
-72.63%
|
$1,066,250
$625.0 P/Share
|
|
Jun 11
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+42.07%
|
$667,046
$391.92 P/Share
|
|
Jun 10
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,512
-9.01%
|
$1,532,320
$610.18 P/Share
|
|
Jun 10
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Jun 10
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
1,706
-11.95%
|
$1,042,366
$611.13 P/Share
|
|
Jun 10
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,706
+42.07%
|
$667,046
$391.92 P/Share
|
|
Jun 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
4,271
-1.77%
|
$2,588,226
$606.43 P/Share
|
|
Jun 09
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
120,234
-30.06%
|
$71,779,698
$597.48 P/Share
|
|
Jun 08
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,229
-6.48%
|
$6,647,568
$592.42 P/Share
|
|
Jun 08
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,500
+8.15%
|
$4,216,000
$272.7 P/Share
|
|
Jun 08
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
10,838
-5.08%
|
$6,426,934
$593.33 P/Share
|
|
Jun 08
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,838
+21.53%
|
$4,476,094
$413.33 P/Share
|
|
Jun 05
2020
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
2,559
-79.92%
|
$1,535,400
$600.0 P/Share
|
|
Jun 05
2020
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+44.42%
|
$1,000,569
$391.92 P/Share
|
|
Jun 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$60,200
$603.0 P/Share
|
|
May 29
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
1,000
-11.67%
|
$596,000
$596.51 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
2,399,552
-85.71%
|
$1,221,371,968
$509.85 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Direct |
20,421,899
-100.0%
|
$10,394,746,591
$509.85 P/Share
|
|
May 28
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
1,000
-13.08%
|
$578,000
$578.94 P/Share
|
|
May 28
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
1,000
-10.23%
|
$579,000
$579.0 P/Share
|
|
May 27
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
73,100
-23.75%
|
-
|
|
May 21
2020
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Direct |
149,594
-1.7%
|
$84,819,798
$567.49 P/Share
|
|
May 20
2020
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
159,642
-9.13%
|
$90,995,940
$570.97 P/Share
|
|
May 20
2020
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
312,500
+12.22%
|
$9,375,000
$30.63 P/Share
|
|
May 15
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
8,380
-36.73%
|
$4,793,360
$572.0 P/Share
|
|
May 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
9,931
-30.32%
|
$5,690,463
$573.18 P/Share
|
|
May 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
18,311
+35.86%
|
$1,080,349
$59.2 P/Share
|
|
May 13
2020
|
Michael S Brown Director |
SELL
Bona fide gift
|
Indirect |
1,000
-8.81%
|
-
|
|
May 13
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
5,000
-4.15%
|
$2,900,000
$580.0 P/Share
|
|
May 13
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.99%
|
$165,000
$33.42 P/Share
|
|
May 12
2020
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Direct |
150,922
-1.3%
|
$85,572,774
$567.49 P/Share
|
|
May 11
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
850
-7.29%
|
$488,750
$575.0 P/Share
|
|
May 11
2020
|
Leonard S Schleifer President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
161,578
-12.1%
|
$92,261,038
$571.43 P/Share
|
|
May 11
2020
|
Leonard S Schleifer President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
312,500
+18.93%
|
$9,375,000
$30.63 P/Share
|
|
May 11
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,305
-8.94%
|
$3,013,240
$568.97 P/Share
|
|
May 08
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,195
-30.13%
|
$4,029,200
$560.67 P/Share
|
|
May 08
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+34.36%
|
$650,000
$52.03 P/Share
|
|
May 07
2020
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
5,118
-33.3%
|
$2,901,906
$567.43 P/Share
|
|
May 07
2020
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,118
+47.04%
|
$2,001,138
$391.92 P/Share
|